1. Home
  2. ARTNA vs BCYC Comparison

ARTNA vs BCYC Comparison

Compare ARTNA & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artesian Resources Corporation

ARTNA

Artesian Resources Corporation

HOLD

Current Price

$34.36

Market Cap

356.0M

Sector

Utilities

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

N/A

Current Price

$4.01

Market Cap

291.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARTNA
BCYC
Founded
1905
2009
Country
United States
United Kingdom
Employees
274
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
356.0M
291.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ARTNA
BCYC
Price
$34.36
$4.01
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$13.90
AVG Volume (30 Days)
26.2K
362.0K
Earning Date
05-12-2026
04-30-2026
Dividend Yield
3.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.82
N/A
Revenue Next Year
$3.54
N/A
P/E Ratio
$15.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.50
$3.87
52 Week High
$34.90
$9.16

Technical Indicators

Market Signals
Indicator
ARTNA
BCYC
Relative Strength Index (RSI) 58.91 38.59
Support Level $31.87 $3.94
Resistance Level $34.86 $4.52
Average True Range (ATR) 0.75 0.18
MACD -0.03 -0.03
Stochastic Oscillator 69.66 13.91

Price Performance

Historical Comparison
ARTNA
BCYC

About ARTNA Artesian Resources Corporation

Artesian Resources Corp operates as a holding company based in the United States. Through its subsidiaries, it offers water, wastewater, and other services in Delaware, Maryland, and Pennsylvania. The Group distributes and sells water, including water for public and private fire protection, to residential, commercial, industrial, municipal, and utility customers. Additionally, it is involved in contract water and wastewater operations; offers wastewater services, and water, sewer, and internal Service Line Protection Plans. The Group operates its businesses mainly through one reportable segment, the Regulated Utility segment.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: